Gregory Grunberg
About Gregory Grunberg
Gregory Grunberg is the Head of Life Sciences, North America, and Managing Director at Temasek, based in San Francisco, California. He has extensive experience in healthcare and life sciences, having held various leadership and board positions at numerous organizations.
Current Role at Temasek
Gregory Grunberg serves as the Head of Life Sciences, North America, and Managing Director at Temasek, based in San Francisco, California. In this role, he oversees and directs investments and strategic initiatives within the life sciences sector across North America. His extensive experience in healthcare and life sciences has positioned him to lead Temasek's efforts to identify and support innovative companies in this region.
Educational Background
Gregory Grunberg has robust academic credentials. He obtained a Bachelor of Arts (B.A.) from Amherst College, followed by a Doctor of Medicine (M.D.) from Duke University School of Medicine. Additionally, he earned an MBA from Duke University - The Fuqua School of Business. His comprehensive educational background in both medicine and business has profoundly informed his career, enabling him to blend medical expertise with strategic business acumen effectively.
Clinical and Teaching Positions
Grunberg has held significant academic and clinical teaching roles, including Clinical Instructor at UCSF Medical Center and Assistant Professor at the University of Miami. For 12 years, he served as a Lecturer at Weill Cornell Medicine, where he imparted his knowledge to medical students and residents. These roles underscore his commitment to education and advancing medical knowledge and practice.
Board and Leadership Experience
Over the years, Gregory Grunberg has amassed considerable experience in board and leadership roles. He served as a Board Member at numerous companies, including Somatus, WelbeHealth, Sydnexis, California Cryobank LLC, and Kala Pharmaceuticals, where he played significant roles in governance and strategic development. He also chaired the Governance Committee at 89bio [Ticker: ETNB] and provided oversight and strategic insights as a Board Observer at several companies, such as Cohere Health, Cortica, and NOCD.
Tenure at Longitude Capital
Before his current role at Temasek, Gregory Grunberg was the Managing Director at Longitude Capital for 11 years. He focused on investments within the life sciences sector, leveraging his medical background and business acumen to identify promising opportunities. His work at Longitude Capital involved rigorous evaluation and strategic guidance, contributing significantly to the firm’s success in the healthcare investment landscape.